ReviewChronic diseases and translational medicine2026
Efficacy and Safety of Durvalumab and Tremelimumab in Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ikhwan Rinaldi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.